Clinical trial
Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive
NCT00185224 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00185224 |
|---|---|
| Title | Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive |
| Official title | A Single-center, Open-label, Controlled, Randomized Study to Investigate the Impact of a Sequential Oral Contraceptive (SH T00658ID) as Compared to a Sequential Oral Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D00264A) on Plasma Lipids, Hemostatic Variables, and Carbohydrate… |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Contraception |
| Intervention type | Drug |
| Interventions | EV/DNG (Qlaira, BAY86-5027, SH T00658K), SH D00264A (Triquilar) |
| Enrollment | 58 |
| Start date | Mar 1, 2005 |
| Completion | Mar 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Jul 15, 2011 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: